Aspeya
Valter Stenskepp serves as the Head of Strategy & Business Development for the Global NRT Category at Aspeya since February 2024. Prior experience includes roles as Managing Director and Head of Sales & Marketing at Niconovum AB from May 2022 to February 2024, Group CMO at Båstadgruppen AB from April 2021 to April 2022, and EMEA Head of Commercial Excellence at Alcon from December 2015 to June 2020. At Alcon, key responsibilities involved enhancing sales and marketing operations across 80 EMEA countries. Other notable positions include Business Consultant & Interim Manager at Stenskepp & Co Aktiebolag, Marketing Manager at Alcon, Group Marketing Manager and Nordic Brand Manager at Johnson & Johnson, and roles at Procter & Gamble. Valter holds a Master's Degree in Marketing - Brand Management from the Stockholm School of Economics and has a background in Communications from North Carolina State University.
This person is not in any teams
This person is not in any offices
Aspeya
We are on a journey to empower healthier lifestyles and target specific unmet needs. We do this by being innovative, optimizing formulas, and applying rigorous scientific standards. This involves harnessing deep insight and scientific substantiation to reimagine how ingredients can be used, and working towards the development and commercialization of a pipeline of wellness and healthcare products and brands. We are applying our expertise to innovate in four areas of focus: Consumer health, cannabinoids, inhaled therapeutics, and nicotine replacement therapy. Our people are open-minded thinkers, leading-edge scientists, and knowledgeable innovators. Want to join our team? Visit our careers site to search for opportunities: careers.aspeya.com